HCTINasdaqServices-Computer Integrated Systems DesignUS GAAP · USD

Healthcare Triangle, Inc.

Healthcare Triangle, Inc. is a U.S.-based healthcare IT services company focused on cloud services, data science, professional services, and managed services for healthcare and life sciences clients. It combines software, platforms, and implementation/support work to help hospitals, payers, biotech, and pharma organizations modernize operations, manage regulated data, and improve digital workflows.

Revenue13.9m USD
+18.8 %y/y
Operating profit (EBIT)-9.8m USD
−106.0 %y/y
EBIT margin-70.5%
−29.8 ppy/y
Net income-9.5m USD
−58.8 %y/y
Free cash flow-16.5m USD
−1,412.3 %y/y

Fiscal year 2025 · change from previous year

Development 2020–2025

-200204060m USD2020: 31 m USD2020: EBIT 1.2 m USD20202021: 35 m USD2021: EBIT -5.4 m USD20212022: 46 m USD2022: EBIT -10 m USD20222023: 33 m USD2023: EBIT -11 m USD20232024: 12 m USD2024: EBIT -4.8 m USD20242025: 14 m USD2025: EBIT -9.8 m USD202514-9.8
RevenueOperating profit (EBIT)

Business

Share of revenue
Software Services57 %

Advisory, implementation, development, and related project work for healthcare and life sciences clients.

Managed Services and Support40 %

Ongoing post-implementation support, cloud hosting, and 24x7 managed operations.

Platform and IP-enabled Solutions3 %

Proprietary or differentiated software platforms delivered as a service for regulated workflows.

Products

Reported · share of revenue
59.4%38.6%FY2025100 %
  • Software Services59.4 %
  • Managed Services and Support38.6 %
  • Corporate and Others2.0 %

Source: 10-K/A FY2025, revenue the company reports per product line (SEC XBRL). Shares are of the lines shown and add up to 100 %.

Customers

The company sells primarily to healthcare and life sciences organizations that need specialized technology services in regulated environments. Its customer base includes hospitals, health systems, payers, biotech firms, and pharma/life sciences companies that buy to modernize systems, improve compliance, and support data-driven workflows.

Hospitals and health systems

Buy EHR implementation, optimization, managed services, and disaster recovery to improve operations and patient workflows.

Payers

Buy cloud, data, and support services to improve claims, member, and care-management workflows.

Life sciences and biotech

Buy analytics, data engineering, and cloud-enabled services for research, drug development, and evidence generation.

Pharma and healthcare enterprises

Buy platform and software services to accelerate digital transformation in regulated environments.

Strategy

Management is focused on scaling sales and marketing, expanding customer reach, and increasing cross-sell between software services and managed services. The company is also investing in systems, controls, governance, and platform development while using acquisitions to broaden its healthcare software footprint.

Scale sales and marketingShort term

The company says growth depends on expanding customer acquisition and geographic reach.

Grow managed services and platform servicesMedium term

Recurring support and platform revenue can improve retention and long-term visibility.

Expand through acquisitionMedium term

Acquisitions can add software assets, customers, and regional presence faster than organic growth alone.

Geography

The company’s disclosures emphasize growth across various geographies, but the provided excerpts do not include a country-by-country revenue table. Operations and customer delivery appear centered on the United States, with the June 2025 acquisition adding assets and a hospital information systems SaaS business in India and exposure across India, Southeast Asia, and Europe.

Risks

The business depends on winning and retaining specialized healthcare clients while scaling delivery in highly regulated markets, which makes execution and compliance critical. It also faces typical services-company risks such as customer concentration, project timing, integration risk from acquisitions, and pressure on margins if sales and delivery costs rise faster than revenue.

Sorted by severity
Customer and project concentrationHigh

Services revenue can be lumpy when a small number of healthcare clients or implementations drive results.

Exposure: Healthcare and life sciences project work

Regulatory and data-security exposureHigh

The company handles sensitive health data in regulated environments, so breaches or compliance failures could lead to loss of business and remediation costs.

ExposureHIPAA-like privacySecurityGovernance obligations
Execution risk in scaling the businessHigh

Management expects higher sales, marketing, and administrative investment, which can pressure margins before revenue scales.

Exposure: Operating leverage and hiring

Acquisition integration riskMedium

The June 2025 asset and equity acquisition adds operational, technical, and cultural integration complexity.

Exposure: Ezovion Solutions and related transferred assets

Accounting

Judgemental items
Revenue recognition and contract assets

Advance billings are recorded as deferred revenue and unbilled services as contract assets, so timing differences can shift reported revenue between periods.

Impact: Affects quarterly revenue, working capital, and comparability

Capitalized software and acquired intangibles

Amortization of software development costs, customer relationships, and other intangibles can materially affect operating profit after acquisitions or platform investment.

Impact: Affects depreciation and amortization expense

Foreign currency and financing costs

Other income/expense includes foreign exchange effects and finance costs, which can be volatile for a company with cross-border operations and financing activity.

Impact: Affects net income and period-to-period volatility

Publicly listed companies with a comparable business focus.

Last updated: 24/09/2026